Skip to content

Opening book details…

About this Biochemistry, Genetics and Molecular Biology article

Phase II study of erlotinib plus gemcitabine in Japanese patients with unresectable pancreatic cancer by Takuji Okusaka; Junji Furuse; Akihiro Funakoshi; Tatsuya Ioka; Kenji Yamao; Shinichi Ohkawa; Narikazu Boku; Yoshito Komatsu; Shoji Nakamori; Haruo Iguchi; Tetsuhide Ito; Kazuhiko Nakagawa; Kohei Nakachi is a Biochemistry, Genetics and Molecular Biology article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Biochemistry, Genetics and Molecular Biology.

Author
Takuji Okusaka; Junji Furuse; Akihiro Funakoshi; Tatsuya Ioka; Kenji Yamao; Shinichi Ohkawa; Narikazu Boku; Yoshito Komatsu; Shoji Nakamori; Haruo Iguchi; Tetsuhide Ito; Kazuhiko Nakagawa; Kohei Nakachi
Publisher
John Wiley and Sons; Wiley (Blackwell Publishing); Wiley-Blackwell; Wiley; Research Square (ISSN 1347-9032)
Published
2011
Language
EN
Field
Biochemistry, Genetics and Molecular Biology (Life Sciences)

More by Takuji Okusaka; Junji Furuse; Akihiro Funakoshi; Tatsuya Ioka; Kenji Yamao; Shinichi Ohkawa; Narikazu Boku; Yoshito Komatsu; Shoji Nakamori; Haruo Iguchi; Tetsuhide Ito; Kazuhiko Nakagawa; Kohei Nakachi

Browse all works by Takuji Okusaka; Junji Furuse; Akihiro Funakoshi; Tatsuya Ioka; Kenji Yamao; Shinichi Ohkawa; Narikazu Boku; Yoshito Komatsu; Shoji Nakamori; Haruo Iguchi; Tetsuhide Ito; Kazuhiko Nakagawa; Kohei Nakachi